Live News Categoriesmarket

VOGX.O (VOGX.O) News

Follow VOGX.O (VOGX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol VOGX.O Asset market Sector Markets 90 days 1 Updated Oct 15, 2026, 08:38 PM UTC Open live news feed

L Vogenx Starts Phase 2b Trial of Mizagliflozin for Post — Bariatric Hypoglycemia Vogenx today initiated EMERGE, a Phase 2b trial of mizagliflozin for post-bariatric hypoglycemia, which has no FDA-approved treatments. The randomized, placebo-controlled study will enroll approximately 36 adults at abou REGULATION | Oct 15, 2026, 08:38 PM UTC